T2 Biosystems (TTOO) Competitors $0.14 +0.00 (+1.82%) As of 07/3/2025 12:05 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TTOO vs. IINN, INBS, WOK, PAVM, SSKN, NURO, BTCY, CODX, SINT, and POAIShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include Inspira Technologies OXY B.H.N. (IINN), Intelligent Bio Solutions (INBS), WORK Medical Technology Group (WOK), PAVmed (PAVM), Strata Skin Sciences (SSKN), NeuroMetrix (NURO), Biotricity (BTCY), Co-Diagnostics (CODX), SINTX TECHNOLOGIES (SINT), and Predictive Oncology (POAI). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. Its Competitors Inspira Technologies OXY B.H.N. Intelligent Bio Solutions WORK Medical Technology Group PAVmed Strata Skin Sciences NeuroMetrix Biotricity Co-Diagnostics SINTX TECHNOLOGIES Predictive Oncology T2 Biosystems (NASDAQ:TTOO) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk. Do institutionals & insiders have more ownership in TTOO or IINN? 23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 0.0% of T2 Biosystems shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is TTOO or IINN more profitable? Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%. Company Net Margins Return on Equity Return on Assets T2 Biosystems-563.16% N/A -174.06% Inspira Technologies OXY B.H.N. N/A N/A N/A Do analysts prefer TTOO or IINN? T2 Biosystems currently has a consensus target price of $5.00, suggesting a potential upside of 3,471.43%. Inspira Technologies OXY B.H.N. has a consensus target price of $2.00, suggesting a potential upside of 70.21%. Given T2 Biosystems' higher possible upside, analysts clearly believe T2 Biosystems is more favorable than Inspira Technologies OXY B.H.N..Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Inspira Technologies OXY B.H.N. 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, TTOO or IINN? Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than T2 Biosystems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioT2 Biosystems$7.68M0.38-$50.08MN/AN/AInspira Technologies OXY B.H.N.N/AN/A-$11.05MN/AN/A Does the media favor TTOO or IINN? In the previous week, Inspira Technologies OXY B.H.N. had 3 more articles in the media than T2 Biosystems. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 0 mentions for T2 Biosystems. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.21 beat T2 Biosystems' score of 0.00 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media. Company Overall Sentiment T2 Biosystems Neutral Inspira Technologies OXY B.H.N. Neutral Which has more volatility and risk, TTOO or IINN? T2 Biosystems has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.24, indicating that its stock price is 124% more volatile than the S&P 500. SummaryInspira Technologies OXY B.H.N. beats T2 Biosystems on 9 of the 12 factors compared between the two stocks. Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TTOO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.95M$247.80M$5.54B$8.95BDividend YieldN/AN/A5.38%4.08%P/E RatioN/A5.9227.4020.04Price / Sales0.3870.58420.62118.79Price / CashN/A196.1236.6357.47Price / Book-0.026.138.085.67Net Income-$50.08M-$26.71M$3.16B$248.47M7 Day Performance-1.20%-0.99%2.84%3.32%1 Month Performance-10.03%-7.01%3.70%5.20%1 Year Performance-97.23%25.94%35.30%21.35% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 Biosystems2.4508 of 5 stars$0.14+1.8%$5.00+3,471.4%-97.2%$2.95M$7.68M0.00180Gap UpIINNInspira Technologies OXY B.H.N.2.8789 of 5 stars$0.85flat$2.00+135.3%-9.6%$10.73MN/A0.0020News CoverageINBSIntelligent Bio Solutions0.3369 of 5 stars$1.72+12.4%N/A+1.1%$10.57M$3.11M0.0010WOKWORK Medical Technology GroupN/A$0.69-3.5%N/AN/A$10.43M$11.51M0.00226Positive NewsGap DownPAVMPAVmed4.3712 of 5 stars$0.60+0.1%$19.00+3,065.1%-15.7%$10.26M$2.99M0.8590SSKNStrata Skin Sciences2.8798 of 5 stars$2.29+1.8%$6.00+162.0%-23.2%$9.39M$33.56M-1.01120Gap DownNURONeuroMetrixN/A$4.55+4.4%N/A+22.0%$9.37M$3.03M-0.9920High Trading VolumeBTCYBiotricityN/A$0.37-7.9%N/A-46.5%$9.23M$12.06M-0.3440News CoverageGap DownCODXCo-Diagnostics4.2155 of 5 stars$0.28+6.7%$5.50+1,862.9%-77.6%$8.81M$3.91M-0.24100Gap UpSINTSINTX TECHNOLOGIES2.4089 of 5 stars$3.22flat$28.00+769.6%-28.5%$8.08M$2.89M-0.0640POAIPredictive Oncology2.1601 of 5 stars$0.83+0.0%$3.00+261.4%-15.6%$7.41M$1.62M-0.2730 Related Companies and Tools Related Companies Inspira Technologies OXY B.H.N. Competitors Intelligent Bio Solutions Competitors WORK Medical Technology Group Competitors PAVmed Competitors Strata Skin Sciences Competitors NeuroMetrix Competitors Biotricity Competitors Co-Diagnostics Competitors SINTX TECHNOLOGIES Competitors Predictive Oncology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTOO) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
